Technology | 2020.11.09
New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer
First randomized clinical trial demonstrating that CTC count may help personalize treatment choices BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 9, 2020 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]c-breast-cancer-301168173.html
